
|Articles|April 4, 2016
Therapeutic Innovation & Regulatory Science (TIRS): Focus on Pharmaceutical Compounding
Author(s)DIA
Advertisement
Pharmaceutical compounding is an essential aspect of medicine in the US, although with inherent risks that must be understood and managed. In May 2016, the Special Section of
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis Investors Share Concerns Over M&A Strategy: Report
2
The Agentic AI Revolution in Biopharma
3
How Cortisol-Targeted Approaches Might be Paired with GLP-1 Medications
4
Boards, AI, and 500 Years of Experience in Life Sciences: Takeaways from the 2026 Life Sciences Board Forum
5




